Robert W Schrier Selected Research

Vasopressin Receptors (Arginine Vasopressin Receptor)

4/2013	Hyponatremia: an update on current pharmacotherapy.
3/2011	Hyponatremia: diagnosis, complications, and management including V2 receptor antagonists.
1/2009	Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
9/2008	Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?
11/2007	Hyponatremia treatment guidelines 2007: expert panel recommendations.
4/2007	The sea within us: disorders of body water homeostasis.
7/2006	Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
4/2006	Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert W Schrier Research Topics

Disease

34	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2018 - 04/2002
21	Heart Failure 05/2015 - 04/2006
16	Hyponatremia 10/2013 - 04/2006
14	Fibrosis (Cirrhosis) 01/2015 - 04/2004
13	Hypertension (High Blood Pressure) 12/2016 - 11/2003
12	Acute Kidney Injury (Acute Renal Failure) 12/2014 - 09/2002
10	Cysts 01/2017 - 01/2005
9	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2017 - 01/2005
7	Chronic Kidney Failure (Chronic Renal Failure) 09/2017 - 11/2003
7	Renal Insufficiency (Renal Failure) 05/2013 - 11/2000
6	Chronic Renal Insufficiency 01/2018 - 06/2010
6	Hypothyroidism 01/2013 - 03/2003
6	Disease Progression 05/2011 - 11/2003
6	Sepsis (Septicemia) 02/2009 - 11/2002
5	Proteinuria 11/2014 - 05/2003
5	Albuminuria 10/2011 - 03/2002
5	Polyuria 04/2010 - 05/2004
5	Endotoxemia 10/2008 - 11/2000
4	Hypotension (Low Blood Pressure) 05/2018 - 03/2012
4	Inflammation (Inflammations) 09/2015 - 06/2010
4	Hyperaldosteronism (Conn Syndrome) 05/2015 - 07/2009
4	Critical Illness (Critically Ill) 09/2011 - 02/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 03/2002
4	Myocardial Infarction 06/2010 - 01/2002
3	Kidney Diseases (Kidney Disease) 09/2017 - 05/2014
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2015 - 06/2010
3	Ascites 01/2015 - 07/2009
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 03/2011
3	Edema (Dropsy) 11/2011 - 07/2006
3	Body Weight (Weight, Body) 10/2011 - 03/2003
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2010 - 06/2007
3	Cardio-Renal Syndrome 12/2009 - 01/2007
3	Nephrogenic Diabetes Insipidus 07/2009 - 04/2007
3	Type 2 Diabetes Mellitus (MODY) 04/2009 - 11/2006
3	Psychogenic Polydipsia 09/2007 - 11/2003
2	Hyperkalemia 12/2014 - 07/2009
2	Septic Shock (Toxic Shock Syndrome) 04/2010 - 10/2008
2	Polydipsia 04/2010 - 05/2004
2	Pulmonary Arterial Hypertension 09/2009 - 09/2008
2	Hypoxia (Hypoxemia) 03/2008 - 06/2007
2	Neoplasms (Cancer) 07/2004 - 09/2002
1	Liver Failure 05/2015
1	Polycystic liver disease 01/2015
1	Hypersplenism (Anemia, Splenic) 01/2015
1	Splenomegaly 01/2015
1	Pain (Aches) 12/2014

Drug/Important Bio-Agent (IBA)

18	SodiumIBA 01/2017 - 11/2002
13	CreatinineIBA 01/2018 - 11/2000
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2016 - 02/2003
12	Vasopressins (Vasopressin)IBA 05/2011 - 10/2005
9	DiureticsIBA 05/2015 - 11/2002
9	Angiotensin Receptor AntagonistsIBA 01/2015 - 01/2002
9	AlbuminsIBA 12/2014 - 03/2002
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2016 - 11/2003
8	Proteins (Proteins, Gene)FDA Link 07/2014 - 04/2002
8	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 04/2013 - 04/2006
7	AngiotensinsIBA 05/2018 - 01/2009
7	ElectrolytesIBA 10/2013 - 07/2004
7	Antidiuretic Hormone Receptor AntagonistsIBA 10/2013 - 04/2006
6	AldosteroneIBA 12/2014 - 07/2006
6	Urea (Carbamide)FDA LinkGeneric 04/2013 - 11/2000
5	Mineralocorticoid Receptor AntagonistsIBA 05/2015 - 07/2009
4	ReninIBA 05/2018 - 01/2009
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2017 - 05/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 09/2007
4	Biomarkers (Surrogate Marker)IBA 09/2015 - 12/2006
4	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 05/2011
4	Antihypertensive Agents (Antihypertensives)IBA 01/2012 - 02/2003
4	GlucocorticoidsIBA 10/2008 - 09/2007
4	Aquaporins (Water Channels)IBA 06/2008 - 11/2003
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2015 - 07/2009
3	Arginine Vasopressin (Argipressin)IBA 04/2013 - 04/2006
3	Tolvaptan FDA Link 05/2011 - 11/2006
3	Valsartan (Vals)FDA Link 01/2011 - 01/2002
3	MineralocorticoidsIBA 09/2008 - 01/2008
3	LipopolysaccharidesIBA 06/2008 - 11/2000
3	NitrogenIBA 05/2008 - 11/2000
3	CaspasesIBA 05/2005 - 04/2002
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014
2	Arachidonic Acid (Vitamin F)IBA 01/2014 - 07/2013
2	SaltsIBA 07/2013 - 05/2011
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2013 - 07/2009
2	Uric Acid (Urate)IBA 02/2013 - 01/2012
2	Natriuretic PeptidesIBA 10/2011 - 07/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 03/2008
2	Hormones (Hormone)IBA 10/2008 - 09/2007
2	Caspase 3 (Caspase-3)IBA 04/2008 - 05/2005
2	CytokinesIBA 03/2008 - 05/2005
2	Caspase InhibitorsIBA 01/2007 - 03/2005
2	Sirolimus (Rapamycin)FDA Link 01/2007 - 01/2005
2	Amitrole (Aminotriazole)IBA 10/2005 - 03/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2003 - 11/2000
1	Fibroblast Growth Factor-23IBA 09/2017
1	Dietary SodiumIBA 01/2017
1	1-dodecylpyridoxal (PLD)IBA 01/2015

Therapy/Procedure

26	Therapeutics 01/2017 - 09/2002
3	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2015 - 11/2004
3	Cell Transplantation 05/2005 - 07/2004
2	Critical Care (Surgical Intensive Care) 03/2011 - 03/2011
2	Resuscitation 04/2010 - 02/2009